Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,823 across all filing types
Latest filing 2020-07-03 Major Shareholding Noti…
Country DK Denmark
Listing CO GMAB

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'Major Shareholder Announcement' and details a change in voting rights controlled by Société Générale S.A., specifically noting that the holding crossed a threshold (4.94% of the share capital). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing thresholds. The filing code for this is MRQ.
2020-07-03 English
Major Shareholding Notification 2020
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled "Major Shareholder Announcement" and details a change in share ownership/voting rights controlled by Société Générale S.A., referencing the Danish Capital Markets Act and specific percentage thresholds (5.03%). This directly corresponds to the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds.
2020-07-03 English
Major Shareholder Announcement
Major Shareholding Notification Classification · 100% confidence The document is explicitly titled 'Major Shareholder Announcement' and references Section 30 of the Danish Capital Markets Act regarding a change in shareholding (Société Générale S.A. crossing the 5% threshold). This aligns perfectly with the definition for 'Major Shareholding Notification'.
2020-07-03 English
6-K Filing
Foreign Filer Report
2020-07-01 English
6-K
Foreign Filer Report
2020-06-30 English
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Share Issue/Capital Change Classification · 100% confidence The document is a formal company announcement regarding a capital increase resulting from the exercise of employee warrants. It details the number of shares issued, the subscription prices, and the resulting change in total share capital. This falls directly under the definition of a share issue or capital change announcement.
2020-06-30 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.